Literature DB >> 23852395

MicroRNAs in heart failure: new targets in disease management.

I Elzenaar1, Y M Pinto, R J van Oort.   

Abstract

Heart failure is the leading cause of mortality in Western society and represents the fastest growing subclass of cardiovascular diseases. An increasing body of evidence indicates an important role for microRNAs (miRNAs) in the pathogenesis and progression of heart failure. miRNAs are small noncoding RNAs that regulate expression of target genes by sequence-specific binding to the 3' untranslated region of messenger RNA, which results in degradation or translational repression. To date, many miRNAs (and their targets) that play a role in diverse aspects of cardiac remodeling and heart failure development have been identified. Here, we give an overview of these miRNAs and their role in cardiac pathogenesis. In addition, we provide brief insight into the potential of miRNAs as novel therapeutic targets for heart failure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852395     DOI: 10.1038/clpt.2013.138

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Association of serum microRNA-21 levels with Visfatin, inflammation, and acute coronary syndromes.

Authors:  Faramarz Darabi; Mahmoud Aghaei; Ahmad Movahedian; Armin Elahifar; Ali Pourmoghadas; Nizal Sarrafzadegan
Journal:  Heart Vessels       Date:  2016-10-26       Impact factor: 2.037

2.  One generation's "junk" is another's treasure: the emerging role of microRNAs as therapeutic targets.

Authors:  Evan L Brittain; Anna R Hemnes
Journal:  J Heart Lung Transplant       Date:  2013-12-27       Impact factor: 10.247

Review 3.  MicroRNAs as monitoring markers for right-sided heart failure and congestive hepatopathy.

Authors:  Ruxandra Florentina Ionescu; Sanda Maria Cretoiu
Journal:  J Med Life       Date:  2021 Mar-Apr

Review 4.  Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs.

Authors:  Agapios Sachinidis
Journal:  Cells       Date:  2020-04-17       Impact factor: 6.600

Review 5.  Non-coding RNAs in Cardiac Regeneration.

Authors:  Ting Yuan; Jaya Krishnan
Journal:  Front Physiol       Date:  2021-03-24       Impact factor: 4.566

Review 6.  MicroRNA-143/-145 in Cardiovascular Diseases.

Authors:  Wang Zhao; Shui-Ping Zhao; Yu-Hong Zhao
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

7.  Desregulated microRNAs in aging-related heart failure.

Authors:  Ran Zhuo; Siyi Fu; Shiyi Li; Mengchao Yao; Dongchao Lv; Tianzhao Xu; Yihua Bei
Journal:  Front Genet       Date:  2014-06-25       Impact factor: 4.599

8.  MicroRNA profiling of pericardial fluid samples from patients with heart failure.

Authors:  Suvi M Kuosmanen; Juha Hartikainen; Mikko Hippeläinen; Hannu Kokki; Anna-Liisa Levonen; Pasi Tavi
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

9.  MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Umesh Chaudhari; Harshal Nemade; John Antonydas Gaspar; Jürgen Hescheler; Jan G Hengstler; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2016-02-03       Impact factor: 5.153

10.  Ghrelin Alleviates Angiotensin II-Induced H9c2 Apoptosis: Impact of the miR-208 Family.

Authors:  Xiaotong Wang; Chunyan Yang; Xueyan Liu; Ping Yang
Journal:  Med Sci Monit       Date:  2018-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.